APA (7th ed.) Citation

Justyna Magdalena Hermanowicz, Bartlomiej Kalaska, Krystyna Pawlak, Beata Sieklucka, Joanna Miklosz, Mariusz Mojzych, & Dariusz Pawlak. (2021). Preclinical Toxicity and Safety of MM-129-First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer. MDPI AG.

Chicago Style (17th ed.) Citation

Justyna Magdalena Hermanowicz, Bartlomiej Kalaska, Krystyna Pawlak, Beata Sieklucka, Joanna Miklosz, Mariusz Mojzych, and Dariusz Pawlak. Preclinical Toxicity and Safety of MM-129-First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate Against Colon Cancer. MDPI AG, 2021.

MLA (9th ed.) Citation

Justyna Magdalena Hermanowicz, et al. Preclinical Toxicity and Safety of MM-129-First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate Against Colon Cancer. MDPI AG, 2021.